These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20231420)

  • 21. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
    Zhang JH; Roddy TP; Ho PI; Horvath CR; Vickers C; Stout S; Hubbard B; Wang YK; Hill WA; Bojanic D
    J Biomol Screen; 2010 Jul; 15(6):695-702. PubMed ID: 20484097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the human soluble epoxide hydrolase in Escherichia coli by auto-induction for the study of high-throughput inhibition assays.
    Nishi K; Kim IH; Ma SJ
    Protein Expr Purif; 2010 Jan; 69(1):34-8. PubMed ID: 19782755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.
    Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ
    Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplex enzyme assays and inhibitor screening by mass spectrometry.
    Rathore R; Pribil P; Corr JJ; Seibel WL; Evdokimov A; Greis KD
    J Biomol Screen; 2010 Sep; 15(8):1001-7. PubMed ID: 20228278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis.
    Dagia NM; Kamath DV; Bhatt P; Gupte RD; Dadarkar SS; Fonseca L; Agarwal G; Chetrapal-Kunwar A; Balachandran S; Srinivasan S; Bose J; Pari K; B-Rao C; Parkale SS; Gadekar PK; Rodge AH; Mandrekar N; Vishwakarma RA; Sharma S
    Eur J Pharmacol; 2009 Apr; 607(1-3):201-12. PubMed ID: 19239912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.
    Trivedi-Parmar V; Jorgensen WL
    J Med Chem; 2018 Sep; 61(18):8104-8119. PubMed ID: 29812929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
    Al-Abed Y; VanPatten S
    Future Med Chem; 2011 Jan; 3(1):45-63. PubMed ID: 21428825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mass spectrometry plate reader: monitoring enzyme activity and inhibition with a Desorption/Ionization on Silicon (DIOS) platform.
    Shen Z; Go EP; Gamez A; Apon JV; Fokin V; Greig M; Ventura M; Crowell JE; Blixt O; Paulson JC; Stevens RC; Finn MG; Siuzdak G
    Chembiochem; 2004 Jul; 5(7):921-7. PubMed ID: 15239048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.
    Swope M; Sun HW; Blake PR; Lolis E
    EMBO J; 1998 Jul; 17(13):3534-41. PubMed ID: 9649424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
    Cheng KF; Al-Abed Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
    Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
    J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase.
    Kleemann R; Kapurniotu A; Frank RW; Gessner A; Mischke R; Flieger O; Jüttner S; Brunner H; Bernhagen J
    J Mol Biol; 1998 Jul; 280(1):85-102. PubMed ID: 9653033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
    Dasgupta M; Tang W; Caldwell GW; Yan Z
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site.
    McLean LR; Zhang Y; Li H; Choi YM; Han Z; Vaz RJ; Li Y
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1821-4. PubMed ID: 20185308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors.
    Mori T; Itami S; Yanagi T; Tatara Y; Takamiya M; Uchida T
    J Biomol Screen; 2009 Apr; 14(4):419-24. PubMed ID: 19403925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a high-throughput fluorescence polarization assay for the discovery of phosphopantetheinyl transferase inhibitors.
    Duckworth BP; Aldrich CC
    Anal Biochem; 2010 Aug; 403(1-2):13-9. PubMed ID: 20382102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plant-derived anti-inflammatory compounds affect MIF tautomerase activity.
    Molnar V; Garai J
    Int Immunopharmacol; 2005 May; 5(5):849-56. PubMed ID: 15778121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New high-throughput fluorimetric assay for discovering inhibitors of UDP-N-acetylmuramyl-L-alanine: D-glutamate (MurD) ligase.
    Kristan K; Kotnik M; Oblak M; Urleb U
    J Biomol Screen; 2009 Apr; 14(4):412-8. PubMed ID: 19403924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of chromenes as inhibitors of macrophage migration inhibitory factor.
    Kok T; Wapenaar H; Wang K; Neochoritis CG; Zarganes-Tzitzikas T; Proietti G; Eleftheriadis N; Kurpiewska K; Kalinowska-Tłuścik J; Cool RH; Poelarends GJ; Dömling A; Dekker FJ
    Bioorg Med Chem; 2018 Mar; 26(5):999-1005. PubMed ID: 29428527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.